projects

Prinicipal Investigator

  • VALPRO

    The randomized-controlled trial tested whether the combination of valproic acid with fear memory retrieval before standard exposure enhances the treatment outcome for patients with fear of spiders. Key collaborating partners were Prof. Dr. Johannes Gräff, the clinic director of the Psychiatric University Clinics Basel Prof. Dr. Undine Lang and Prof. Dr. Dominique de Quervain. Preregristration on ClinicalTrials.gov and first results.

  • Hypothalamic-pituitary-adrenal axis functioning in anxiety disorders

    With a meta-analytic approach, we summarize the current state of research on the functionality of the hypothalamic-pituitary-adrenal axis in anxiety disorders. Key collaborating partner is Dr. Susanne Fischer from the University of Zurich. PROSPERO preregistration.

  • Hormones, conduct disorder, and callous-unemotional traits

    With a meta-analytic approach, we investigate the relationships between hormones and callous-unemotional traits, as well as conduct disorder, in children and adolescents. Co-Principal investigator is Dr. Loreen Tisdall form the University of Basel. PROSPERO preregistration.

  • Common triggers of contamination obsessive-compulsive symptoms

    In the project we collected common triggers of contamination obsessive-compulsive symptoms (OCS) in a large Swiss population, along with the trigger severity, as well as the intensity of the obsessive-compulsive symptoms. We analyzed the collected information with an approach using large language models, and generated a map of OCS triggers by assessing their similarity through embeddings. Key collaborating partner is Dr. Dirk Wulff from the MPI for Human Development, Berlin, Germany.

  • Mental representations of contamination obsessive-compulsive triggers

    The project aims to characterize contamination obsessive-compulsive stimuli based on theoretically guided dimensions as well as data-driven dimensions. Methodologically, similarity judgment is used to identify underlying dimensions, which are then analyzed using multidimensional scaling. The results have the potential to guide the development of new treatment approaches. Key collaborating partner is Dr. Filip Melinscak and the clinic director of the Psychiatric Hospital St. Gallen PD Dr. Steffi Weidt.

Co-investigator

  • OCD-Detect

    The project investigates the feasibility and acceptance of a wearable for automatic detection of compulsive hand-washing in a clinical population with obsessive-compulsive disorder. Principal investigator of the project is PD. Dr. Karina Wahl from the University of Basel.

projects

Prinicipal Investigator

  • VALPRO

    The randomized-controlled trial tested whether the combination of valproic acid with fear memory retrieval before standard exposure enhances the treatment outcome for patients with fear of spiders. Key collaborating partners were Prof. Dr. Johannes Gräff, the clinic director of the Psychiatric University Clinics Basel Prof. Dr. Undine Lang and Prof. Dr. Dominique de Quervain. Preregristration on ClinicalTrials.gov and first results.

  • Hypothalamic-pituitary-adrenal axis functioning in anxiety disorders

    With a meta-analytic approach, we summarize the current state of research on the functionality of the hypothalamic-pituitary-adrenal axis in anxiety disorders. Key collaborating partner is Dr. Susanne Fischer from the University of Zurich. PROSPERO preregistration.

  • Hormones, conduct disorder, and callous-unemotional traits

    With a meta-analytic approach, we investigate the relationships between hormones and callous-unemotional traits, as well as conduct disorder, in children and adolescents. Co-Principal investigator is Dr. Loreen Tisdall form the University of Basel. PROSPERO preregistration.

  • Common triggers of contamination obsessive-compulsive symptoms

    In the project we collected common triggers of contamination obsessive-compulsive symptoms (OCS) in a large Swiss population, along with the trigger severity, as well as the intensity of the obsessive-compulsive symptoms. We analyzed the collected information with an approach using large language models, and generated a map of OCS triggers by assessing their similarity through embeddings. Key collaborating partner is Dr. Dirk Wulff from the MPI for Human Development, Berlin, Germany.

  • Mental representations of contamination obsessive-compulsive triggers

    The project aims to characterize contamination obsessive-compulsive stimuli based on theoretically guided dimensions as well as data-driven dimensions. Methodologically, similarity judgment is used to identify underlying dimensions, which are then analyzed using multidimensional scaling. The results have the potential to guide the development of new treatment approaches. Key collaborating partner is Dr. Filip Melinscak and the clinic director of the Psychiatric Hospital St. Gallen PD Dr. Steffi Weidt.

Co-investigator

  • OCD-Detect

    The project investigates the feasibility and acceptance of a wearable for automatic detection of compulsive hand-washing in a clinical population with obsessive-compulsive disorder. Principal investigator of the project is PD. Dr. Karina Wahl from the University of Basel.